Showing results (1-10 of 307) with videos related to

Sort By:
Pageof 31
Expert Reviews in Molecular Medicine|March 6, 2009
FOXA1 in breast cancerHarikrishna Nakshatri, Sunil Badve
Expert Opinion on Therapeutic Targets|March 22, 2007
FOXA1 as a therapeutic target for breast cancerHarikrishna Nakshatri, Sunil Badve
The Lancet. Oncology|January 10, 2012
Breast-cancer stem cells-beyond semanticsSunil Badve, Harikrishna Nakshatri
Current Stem Cell Research & Therapy|January 20, 2009
Breast cancer stem cells and intrinsic subtypes: controversies rage onHarikrishna Nakshatri, Edward F Srour, Sunil Badve
Biomarkers in Medicine|October 19, 2011
Biomarkers for breast cancer stem cells: the challenges aheadYesim Gökmen-Polar, Harikrishna Nakshatri, Sunil Badve
Cancer Research|July 9, 2013
ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancerDaohong Chen, Poornima Bhat-Nakshatri, Chirayu Goswami, et al.
Oncology Reports|September 30, 2010
Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse modelKasi McCune, Rutika Mehta, Mangesh A Thorat, et al.
Carcinogenesis|September 26, 2007
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnoverNagendra K Prasad, Manish Tandon, Sunil Badve, et al.
Cancer Biology & Therapy|July 7, 2010
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancerHitesh Appaiah, Poornima Bhat-Nakshatri, Rutika Mehta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2009
Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scoresFoluso O Ademuyiwa, Mangesh A Thorat, Rohit K Jain, et al.
Pageof 31